Insmed Incorporated (INSM)
USD 72.3
(-0.47%)
USD 72.3
(-0.47%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.19 Billion USD | 2.02% |
| 2022 | 1.16 Billion USD | 94.27% |
| 2021 | 602.13 Million USD | 53.49% |
| 2020 | 392.28 Million USD | 1.95% |
| 2019 | 384.77 Million USD | 21.55% |
| 2018 | 316.55 Million USD | 469.69% |
| 2017 | 55.56 Million USD | 1.42% |
| 2016 | 54.79 Million USD | 148.74% |
| 2015 | 22.02 Million USD | -11.38% |
| 2014 | 24.85 Million USD | 52.14% |
| 2013 | 16.33 Million USD | 0.33% |
| 2012 | 16.28 Million USD | 1395.41% |
| 2011 | 1.08 Million USD | 1212.05% |
| 2010 | 83 Thousand USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 487 Thousand USD | -76.95% |
| 2007 | 2.11 Million USD | -33.15% |
| 2006 | 3.16 Million USD | -50.89% |
| 2005 | 6.43 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 989.36 Million USD | 13.29% |
| 2024 Q2 | 1.1 Billion USD | 4.79% |
| 2024 Q1 | 1.09 Billion USD | -18.72% |
| 2023 Q1 | 1.17 Billion USD | 0.51% |
| 2023 FY | 1.19 Billion USD | 2.02% |
| 2023 Q3 | 1.18 Billion USD | 0.61% |
| 2023 Q4 | 1.19 Billion USD | 0.43% |
| 2023 Q2 | 1.18 Billion USD | 0.45% |
| 2022 Q4 | 1.16 Billion USD | 41.96% |
| 2022 Q2 | 825.31 Million USD | -0.15% |
| 2022 Q1 | 826.54 Million USD | 37.27% |
| 2022 FY | 1.16 Billion USD | 94.27% |
| 2022 Q3 | 823.98 Million USD | -0.16% |
| 2021 Q3 | 594.05 Million USD | 1.33% |
| 2021 FY | 602.13 Million USD | 53.49% |
| 2021 Q1 | 400.06 Million USD | 1.98% |
| 2021 Q2 | 586.26 Million USD | 46.55% |
| 2021 Q4 | 602.13 Million USD | 1.36% |
| 2020 FY | 392.28 Million USD | 1.95% |
| 2020 Q1 | 387.33 Million USD | 0.66% |
| 2020 Q2 | 389.95 Million USD | 0.68% |
| 2020 Q3 | 389.32 Million USD | -0.16% |
| 2020 Q4 | 392.28 Million USD | 0.76% |
| 2019 Q2 | 359.65 Million USD | 0.74% |
| 2019 Q3 | 362.42 Million USD | 0.77% |
| 2019 Q4 | 384.77 Million USD | 6.17% |
| 2019 Q1 | 357.02 Million USD | 12.78% |
| 2019 FY | 384.77 Million USD | 21.55% |
| 2018 FY | 316.55 Million USD | 469.69% |
| 2018 Q4 | 316.55 Million USD | 1.51% |
| 2018 Q3 | 311.86 Million USD | 1.53% |
| 2018 Q2 | 307.15 Million USD | 1.47% |
| 2018 Q1 | 302.7 Million USD | 444.76% |
| 2017 Q4 | 55.56 Million USD | 0.32% |
| 2017 Q3 | 55.38 Million USD | 0.35% |
| 2017 Q2 | 55.19 Million USD | 0.37% |
| 2017 Q1 | 54.99 Million USD | 0.37% |
| 2017 FY | 55.56 Million USD | 1.42% |
| 2016 Q3 | 34.68 Million USD | 114.93% |
| 2016 FY | 54.79 Million USD | 148.74% |
| 2016 Q4 | 54.79 Million USD | 57.99% |
| 2016 Q2 | 16.13 Million USD | -15.58% |
| 2016 Q1 | 19.11 Million USD | -13.22% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2015 FY | 22.02 Million USD | -11.38% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | 22.02 Million USD | 0.0% |
| 2014 Q2 | 16.49 Million USD | 13.21% |
| 2014 Q3 | 14.71 Million USD | -10.8% |
| 2014 Q4 | 24.85 Million USD | 68.94% |
| 2014 FY | 24.85 Million USD | 52.14% |
| 2014 Q1 | 14.56 Million USD | -10.83% |
| 2013 Q1 | 14.55 Million USD | -10.6% |
| 2013 Q4 | 16.33 Million USD | 30.14% |
| 2013 FY | 16.33 Million USD | 0.33% |
| 2013 Q3 | 12.55 Million USD | -15.89% |
| 2013 Q2 | 14.92 Million USD | 2.52% |
| 2012 Q4 | 16.28 Million USD | 89.74% |
| 2012 Q2 | 9.85 Million USD | 902.03% |
| 2012 Q1 | 983 Thousand USD | -9.73% |
| 2012 FY | 16.28 Million USD | 1395.41% |
| 2012 Q3 | 8.58 Million USD | -12.86% |
| 2011 Q1 | 71 Thousand USD | -14.46% |
| 2011 FY | 1.08 Million USD | 1212.05% |
| 2011 Q4 | 1.08 Million USD | 2320.0% |
| 2011 Q3 | 45 Thousand USD | -22.41% |
| 2011 Q2 | 58 Thousand USD | -18.31% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | 83 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | 83 Thousand USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2008 FY | 487 Thousand USD | -76.95% |
| 2008 Q2 | 1.34 Million USD | -22.42% |
| 2008 Q3 | 820 Thousand USD | -39.08% |
| 2008 Q4 | 487 Thousand USD | -40.61% |
| 2008 Q1 | 1.73 Million USD | -17.89% |
| 2007 Q1 | 3.23 Million USD | 2.31% |
| 2007 Q2 | 2.57 Million USD | -20.41% |
| 2007 Q4 | 2.11 Million USD | -6.55% |
| 2007 FY | 2.11 Million USD | -33.15% |
| 2007 Q3 | 2.26 Million USD | -12.16% |
| 2006 Q1 | 3.47 Million USD | -46.03% |
| 2006 Q4 | 3.16 Million USD | -12.78% |
| 2006 Q3 | 3.62 Million USD | 2.17% |
| 2006 Q2 | 3.54 Million USD | 2.1% |
| 2006 FY | 3.16 Million USD | -50.89% |
| 2005 Q4 | 6.43 Million USD | -73.37% |
| 2005 FY | 6.43 Million USD | 0.0% |
| 2005 Q3 | 24.17 Million USD | 22.01% |
| 2005 Q1 | 18.63 Million USD | 0.0% |
| 2005 Q2 | 19.81 Million USD | 6.35% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Absci Corporation | 4.66 Million USD | -25508.412% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -813.326% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 49.068% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -446848.315% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -5985814.928% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -2877.425% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -10563.497% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -1086.258% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -6215.703% |
| Chimerix, Inc. | 125 Thousand USD | -954581.6% |
| CRISPR Therapeutics AG | 223 Million USD | -435.119% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -519.537% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -24224.338% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1860.944% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1860.944% |
| Gritstone bio, Inc. | 40.14 Million USD | -2872.678% |
| Allakos Inc. | 38.21 Million USD | -3022.732% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -381.935% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -3118.404% |
| Cytokinetics, Incorporated | 607.37 Million USD | -96.478% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -12848.698% |
| Innoviva, Inc. | 446.23 Million USD | -167.427% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -4532878.804% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -26668.775% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -9118.633% |
| ImmuCell Corporation | 10.54 Million USD | -11221.592% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -105975.733% |
| Incyte Corporation | 29.16 Million USD | -3992.147% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -10717.122% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -876249.937% |
| Mustang Bio, Inc. | 1.97 Million USD | -60231.244% |
| MiMedx Group, Inc. | 48.09 Million USD | -2381.033% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 30.19 Million USD | -3852.02% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 5.3 Million USD | -22416.075% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -1153.666% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -130.063% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1355.009% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -877364.706% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -1634628.767% |
| NextCure, Inc. | 5.94 Million USD | -19959.708% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -114866.474% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 118.85 Thousand USD | -1003923.322% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -822901.379% |
| Opthea Limited | 200.53 Million USD | -495.082% |
| Ovid Therapeutics Inc. | 30 Million USD | -3877.84% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| PDS Biotechnology Corporation | 19.5 Million USD | -6017.814% |
| Precigen, Inc. | 5.89 Million USD | -20143.461% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -27289.305% |
| PureTech Health plc | 18.25 Million USD | -6438.915% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -5245.122% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 55.849% |
| Replimune Group, Inc. | 71.99 Million USD | -1557.664% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -2166.231% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -3116433.911% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -1381.045% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -3460.65% |
| Solid Biosciences Inc. | 23.94 Million USD | -4884.554% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -202851.02% |
| SciSparc Ltd. | 24 Thousand USD | -4972200.0% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -700.295% |
| TG Therapeutics, Inc. | 100.11 Million USD | -1091.946% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -18088.569% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -216.318% |
| UroGen Pharma Ltd. | 98.55 Million USD | -1110.898% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -2683.393% |
| XOMA Corporation | 118.51 Million USD | -906.895% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -2665.59% |
| AbCellera Biologics Inc. | 71.22 Million USD | -1575.538% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -36747.421% |
| Precision BioSciences, Inc. | 7.72 Million USD | -15351.923% |
| Dyadic International, Inc. | 88.87 Thousand USD | -1342706.346% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -864647.826% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -5424227.273% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -1205306.061% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -14623.652% |
| IGM Biosciences, Inc. | 34.67 Million USD | -3341.832% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -2086.828% |
| Acelyrin, Inc. | 1.19 Million USD | -99845.729% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -27009.314% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -20635.917% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -1324022.32% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -4506.292% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -3353.386% |
| Senti Biosciences, Inc. | 33.53 Million USD | -3458.209% |
| Mesoblast Limited | 100.48 Million USD | -1087.616% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -1423.512% |
| ChromaDex Corporation | 2.57 Million USD | -46243.767% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -1576.15% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -4496.179% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -525.014% |
| Novavax, Inc. | 168.01 Million USD | -610.261% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -1125.711% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -1997.501% |
| Celcuity Inc. | 37.03 Million USD | -3122.192% |
| ContextLogic Inc. | 6 Million USD | -19789.2% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -762.847% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -31295.738% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 76.638% |
| Amarin Corporation plc | 8.73 Million USD | -13558.601% |
| AnaptysBio, Inc. | 16.03 Million USD | -7341.242% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -22011.395% |
| Aptorum Group Limited | 3.05 Million USD | -38917.558% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -13477.79% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -1040.785% |
| Ardelyx, Inc. | 51.54 Million USD | -2215.076% |
| Celularity Inc. | 26.17 Million USD | -4458.781% |
| Omeros Corporation | 329.7 Million USD | -261.945% |
| Humacyte, Inc. | 38.6 Million USD | -2991.585% |
| Immunocore Holdings plc | 82.64 Million USD | -1343.967% |
| IO Biotech, Inc. | 1.83 Million USD | -64791.354% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -81748.56% |
| Summit Therapeutics Inc. | 103.29 Million USD | -1055.341% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 8.32 Million USD | -14231.116% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -1133.477% |
| Evogene Ltd. | 10.65 Million USD | -11102.028% |
| CorMedix Inc. | 517.01 Thousand USD | -230716.633% |
| BioLineRx Ltd. | 6.62 Million USD | -17904.707% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -75909.682% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -319.879% |
| scPharmaceuticals Inc. | 38.81 Million USD | -2974.778% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -13729.552% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -4680.292% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -7955580.0% |
| Lisata Therapeutics, Inc. | 137.00 USD | -871059754.015% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -24902.137% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -185780.374% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -30391.844% |
| bluebird bio, Inc. | 224.41 Million USD | -431.752% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -101.208% |
| DBV Technologies S.A. | 4.52 Million USD | -26266.593% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -19107.339% |
| Galecto, Inc. | 66 Thousand USD | -1808009.091% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -31562.298% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -69402.155% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -476.588% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -1785179.157% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -491.357% |
| ADMA Biologics, Inc. | 130.59 Million USD | -813.788% |
| Clene Inc. | 7.15 Million USD | -16585.57% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -108288.011% |
| Aptose Biosciences Inc. | 621 Thousand USD | -192066.184% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -117944.501% |
| Century Therapeutics, Inc. | 46.65 Million USD | -2457.658% |
| Kura Oncology, Inc. | 9.33 Million USD | -12687.741% |
| Surrozen, Inc. | 882 Thousand USD | -135200.68% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -4369.483% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -12615.525% |
| Autolus Therapeutics plc | 47.91 Million USD | -2390.612% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -17519.253% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -4506.114% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -5082.853% |
| INmune Bio, Inc. | 397 Thousand USD | -300492.443% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -586.809% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -29334.521% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -3750.392% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -811985.826% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -2297.637% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -2742.126% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -2511.674% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -152.098% |
| Verastem, Inc. | 40.08 Million USD | -2876.979% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -11769.425% |
| Histogen Inc. | 4.38 Million USD | -27120.62% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -2396.552% |
| Surrozen, Inc. | 882 Thousand USD | -135200.68% |
| Organovo Holdings, Inc. | 888 Thousand USD | -134286.486% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -1476.423% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -1281640.849% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -4602.124% |
| Turnstone Biologics Corp. | 1.18 Million USD | -100266.022% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -1094718.349% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -1878.336% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -1355.148% |
| Exelixis, Inc. | 189.94 Million USD | -528.265% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -5060.441% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -1182.719% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -65685.667% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -676.957% |
| MediWound Ltd. | 6.35 Million USD | -18692.945% |
| OmniAb, Inc. | 22.07 Million USD | -5305.898% |
| Alector, Inc. | 30.45 Million USD | -3818.282% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -1075.207% |
| Zai Lab Limited | 8.04 Million USD | -14729.775% |
| AlloVir, Inc. | 16.64 Million USD | -7068.14% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -179.739% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -15994431.564% |
| Aura Biosciences, Inc. | 16.87 Million USD | -6973.811% |
| Immunic, Inc. | 639 Thousand USD | -186653.052% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -3901.985% |
| Veracyte, Inc. | 7.52 Million USD | -15758.498% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -85.055% |
| FibroGen, Inc. | 89.69 Million USD | -1230.426% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -27415.61% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -37332.622% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -911809.401% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -3225175.676% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -60170.303% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 26.896% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -19739.601% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -65685.667% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -8779.768% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -259324.348% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -5464.191% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -3164.538% |
| Agenus Inc. | 137.32 Million USD | -769.005% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -230722.437% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -2538.058% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -3803.16% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -2563.613% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -47.098% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -265648.586% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -1714.791% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -377543.038% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -1940435.97% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 5.92 Million USD | -20052.676% |
| Pluri Inc. | 29.05 Million USD | -4007.5% |
| Prothena Corporation plc | 10.72 Million USD | -11030.977% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -5911.546% |
| Rallybio Corporation | 173 Thousand USD | -689698.844% |
| Kodiak Sciences Inc. | 100 Million USD | -1093.352% |
| Cue Biopharma, Inc. | 4.2 Million USD | -28299.619% |
| MeiraGTx Holdings plc | 72.11 Million USD | -1554.698% |
| Annexon, Inc. | 29.19 Million USD | -3988.222% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -106259.358% |
| Moderna, Inc. | - USD | -Infinity% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -73883.385% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -33261.812% |
| Blueprint Medicines Corporation | 610.96 Million USD | -95.323% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -2683.198% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -2351.22% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -4597.496% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -1212.804% |
| Elicio Therapeutics, Inc. | 6 Million USD | -19766.023% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -254346.055% |
| Nutriband Inc. | 79.82 Thousand USD | -1494841.498% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -26513.559% |
| Vor Biopharma Inc. | 31.83 Million USD | -3649.142% |
| Roivant Sciences Ltd. | 477.85 Million USD | -149.73% |
| Alkermes plc | 287.73 Million USD | -314.747% |
| ProKidney Corp. | 3.61 Million USD | -32956.842% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -157126.877% |
| Arcellx, Inc. | 50.84 Million USD | -2247.224% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 31.247% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -3139.459% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -1563.417% |
| Atai Life Sciences N.V. | 15.21 Million USD | -7745.322% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -141562.818% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -467881.176% |
| MediciNova, Inc. | 410.66 Thousand USD | -290493.678% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -87069.613% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -179865.887% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -570.159% |
| Biomea Fusion, Inc. | 7.83 Million USD | -15140.766% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -55404.744% |
| Geron Corporation | 35.05 Million USD | -3304.616% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -10257.16% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -5158.215% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -11827.556% |
| Royalty Pharma plc | 6.13 Billion USD | 80.549% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -10272.464% |
| Imunon, Inc. | 1.13 Million USD | -104644.96% |
| BioAtla, Inc. | 836 Thousand USD | -142645.455% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -1250.771% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -25241.941% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -5055.314% |
| Structure Therapeutics Inc. | 4.01 Million USD | -29637.154% |
| 89bio, Inc. | 24.79 Million USD | -4712.874% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -11751.743% |
| aTyr Pharma, Inc. | 13.76 Million USD | -8568.207% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -15007.634% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -5806.221% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -428870.128% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -8155.716% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 20.403% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -1099.252% |
| Liquidia Corporation | 2.36 Million USD | -50380.203% |
| Entera Bio Ltd. | 256 Thousand USD | -466053.125% |
| GH Research PLC | 631 Thousand USD | -189020.761% |
| Vericel Corporation | 81.85 Million USD | -1357.867% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -17063.124% |
| Xencor, Inc. | 14.64 Million USD | -8050.198% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -794138.973% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -795468.0% |
| Vaxcyte, Inc. | 22.11 Million USD | -5297.096% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -12325.573% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -16933.286% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -876249.937% |
| Portage Biotech Inc. | 7000.00 USD | -17047785.714% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -179865.887% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -83409.587% |
| OncoCyte Corporation | 2.2 Million USD | -54044.828% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -1783551.446% |
| Purple Biotech Ltd. | 163 Thousand USD | -732017.791% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -18950.958% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -98851.244% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -243441.224% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -46975.03% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -251662.025% |
| United Therapeutics Corporation | 300 Million USD | -297.784% |
| HilleVax, Inc. | 25.24 Million USD | -4627.27% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -618.432% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -127804.823% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -64301.079% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -5837.37% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -4429.194% |
| Windtree Therapeutics, Inc. | 15 Million USD | -7855.68% |
| Curis, Inc. | 1.48 Million USD | -80044.527% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -170937.171% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -19889100.0% |
| BeiGene, Ltd. | 197.61 Million USD | -503.868% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -2199.817% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -88956.119% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -31579.108% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -128493.966% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -6732.038% |
| Adicet Bio, Inc. | 17.7 Million USD | -6640.959% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -207.678% |
| Aditxt, Inc. | 1.04 Million USD | -114453.288% |
| Adagene Inc. | 13.54 Million USD | -8713.508% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -8587.137% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -6881.525% |
| Compugen Ltd. | 719 Thousand USD | -165873.853% |
| Generation Bio Co. | 89.77 Million USD | -1229.285% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -5279.094% |
| Invivyd, Inc. | 722 Thousand USD | -165184.211% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -2360.418% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -40815980.828% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -31098.745% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -5188386.957% |
| 2seventy bio, Inc. | 244.01 Million USD | -389.053% |
| Instil Bio, Inc. | 81.42 Million USD | -1365.548% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -35245.393% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -1822117.472% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -453879.039% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -12280.454% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -968.613% |
| Evaxion Biotech A/S | 8.48 Million USD | -13958.043% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -1492.729% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -1744.011% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -19098.069% |
| Cingulate Inc. | 135.09 Thousand USD | -883216.679% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -4969.68% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -662873.333% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -6743.792% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -127394.872% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -933.384% |
| ImmunityBio, Inc. | 836.95 Million USD | -42.583% |
| Korro Bio, Inc. | 31.21 Million USD | -3722.886% |
| Kineta, Inc. | 150 Thousand USD | -795468.0% |
| BioVie Inc. | 349.89 Thousand USD | -340961.007% |
| Codexis, Inc. | 12.24 Million USD | -9647.219% |
| Celularity Inc. | 26.17 Million USD | -4458.781% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -1205.494% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -2409.414% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -676614.395% |
| Cibus, Inc. | 17.67 Million USD | -6652.02% |
| IN8bio, Inc. | 3.37 Million USD | -35216.721% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -1746.522% |
| Avalo Therapeutics, Inc. | 2 Million USD | -59567.6% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 14.783% |
| Eyenovia, Inc. | 8.95 Million USD | -13222.778% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -1717.5% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -3859.757% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -14556.743% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -81748.56% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -5518.947% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -113013.934% |
| Moolec Science SA | 99.04 Thousand USD | -1204746.233% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -4220.452% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -201820.812% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -72576.736% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -222540.299% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -3759436.261% |
| Humacyte, Inc. | 38.6 Million USD | -2991.585% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -9497.491% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -63852.412% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -115534.884% |
| Notable Labs, Ltd. | 1.52 Million USD | -78101.311% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -8587.137% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -376351.735% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -2292.59% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -917863.077% |
| PepGen Inc. | 17.1 Million USD | -6878.667% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -28566.693% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -206362.284% |
| XOMA Corporation | 118.51 Million USD | -906.895% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -3225175.676% |
| Bionomics Limited | 117.62 Million USD | -914.514% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -21171.872% |
| uniQure N.V. | 130.06 Million USD | -817.504% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -1936.784% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -173858.017% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -27415.61% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -86062.599% |
| Altimmune, Inc. | 175 Thousand USD | -681815.429% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -21171.872% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -23456.099% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1311.332% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -11917.644% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -18607.509% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -11917.644% |
| argenx SE | 15.35 Million USD | -7672.255% |
| Immunome, Inc. | 1.34 Million USD | -88956.119% |
| Verona Pharma plc | 48.37 Million USD | -2366.929% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -12848.698% |
| Shattuck Labs, Inc. | 3.4 Million USD | -34936.759% |
| CervoMed Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -1403843.529% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -710228.571% |
| Moolec Science SA | 99.04 Thousand USD | -1204746.233% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -51029.049% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Achilles Therapeutics plc | 1.07 Million USD | -110806.32% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -9179530.769% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -248.442% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -4774.008% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -47634.271% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -615029.897% |
| Beam Therapeutics Inc. | 159.91 Million USD | -646.26% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -289.449% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -143159.544% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -1994738.019% |
| NeurAxis, Inc. | 27.07 Thousand USD | -4408130.209% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -119235.2% |
| Lumos Pharma, Inc. | 6 Million USD | -19789.2% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -7027.71% |
| Palisade Bio, Inc. | 90 Thousand USD | -1325846.667% |
| Nutriband Inc. | 79.82 Thousand USD | -1494841.498% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -2845.966% |
| Neurogene Inc. | 13.37 Million USD | -8823.592% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -4443.853% |
| Athira Pharma, Inc. | 1.21 Million USD | -97956.861% |
| HCW Biologics Inc. | 6.3 Million USD | -18829.121% |
| XOMA Corporation | 118.51 Million USD | -906.895% |
| Nektar Therapeutics | 112.62 Million USD | -959.58% |
| Arvinas, Inc. | 800 Thousand USD | -149069.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -8155.716% |
| Merus N.V. | 10.48 Million USD | -11278.261% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -7917.145% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -8786.38% |
| Rezolute, Inc. | 1.66 Million USD | -71788.675% |
| Clene Inc. | 7.15 Million USD | -16585.57% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -1626872.787% |
| BeyondSpring Inc. | 3.36 Million USD | -35374.197% |
| Synlogic, Inc. | 12.49 Million USD | -9453.695% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -3554.312% |
| Krystal Biotech, Inc. | 6.62 Million USD | -17926.465% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -598.197% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -19802.468% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -2519061.512% |
| MannKind Corporation | 252.15 Million USD | -373.269% |
| Ikena Oncology, Inc. | 7.18 Million USD | -16520.501% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -599574.372% |
| Gossamer Bio, Inc. | 197.4 Million USD | -504.52% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -229390.769% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -324.185% |
| Mural Oncology plc | 8.91 Million USD | -13291.898% |
| Disc Medicine, Inc. | 1.43 Million USD | -83002.507% |
| Champions Oncology, Inc. | 6.09 Million USD | -19485.623% |
| REGENXBIO Inc. | 82.22 Million USD | -1351.378% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -241467.764% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -26813.667% |
| Vaxart, Inc. | 2.62 Million USD | -45395.692% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -439228.354% |
| Cellectis S.A. | 36.24 Million USD | -3192.823% |
| Longeveron Inc. | 1.44 Million USD | -82313.812% |
| Repare Therapeutics Inc. | 1.01 Million USD | -118053.663% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | -5.372% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -2565.577% |
| Revolution Medicines, Inc. | 80.57 Million USD | -1381.045% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -37099.252% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -674110.169% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -970104.878% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -64.668% |
| Denali Therapeutics Inc. | 44.98 Million USD | -2553.013% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -9443.571% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -883216.679% |
| Passage Bio, Inc. | 22.92 Million USD | -5106.37% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -19660.755% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -184343.895% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -5817.937% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -292778.021% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -100350.505% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -255984.12% |
| OmniAb, Inc. | 22.07 Million USD | -5305.898% |
| Anew Medical, Inc. | 1.54 Million USD | -77390.39% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -3937.052% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -13111.026% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -3738.379% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -29334.521% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -2214.627% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -18642.767% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -8346.118% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -177482.143% |
| Alumis Inc. Common Stock | 30.86 Million USD | -3766.986% |
| Equillium, Inc. | 384 Thousand USD | -310668.75% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -19275.743% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -39310.568% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -6035160.203% |
| vTv Therapeutics Inc. | 169 Thousand USD | -706025.444% |
| Bio-Techne Corporation | 319 Million USD | -274.092% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -1994.041% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -568.297% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -7645.518% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -9537.018% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -24725.296% |
| Nkarta, Inc. | 82.27 Million USD | -1350.531% |
| BioCardia, Inc. | 982 Thousand USD | -121422.607% |
| Iterum Therapeutics plc | 18.95 Million USD | -6195.379% |